Close Menu

Montreal Heart Institute

Although analyses for other drugs in the class have failed to confirm the influence of genotype, Dalcor is moving forward with its clinical trial, expecting some results by the end of this year.

The genetics center has launched an NGS panel for inherited cardiovascular diseases and plans to develop pharmacogenomics and cholesterol metabolism panels.

Vanderbilt University, the University of Colorado at Denver, Partners HealthCare, and the Montreal Heart Institute will use Illumina technology to analyze their biobank samples.

The partners are using genomic data to improve understanding of cardiovascular disease and diabetes and identify markers linked to drug response.

The study found a strong association between the effects of dalcetrapib and a genetic variant in the gene ADCY9.

NEW YORK (GenomeWeb News) – The Montreal Heart Institute has partnered with several biotech companies and the Quebec government to launch a C$49.2 million (US$44.6 million) research program to that will use genetic and other biomarkers to develop personalized treatments for cardiovascular disease

By Monica Heger
This story was originally published Oct. 3.

Researchers at the institute have already used the system to sequence the TNNT2 gene in a number of clinical samples from a French Canadian cohort.

Pages

Bloomberg reports that the DNA-for-cash deal reported in Kentucky might be a more widespread scam.

St. Jude Children's Research Hospital scientists have treated infants with X-linked severe combined immunodeficiency using gene therapy in an early phase study.

St. Louis Public Radio reports that some African Americans are turning to DNA ancestry testing to help guide genealogical searches.

In Nature this week: a genomic analysis of the snailfish Pseudoliparis swirei, ancient DNA analysis gives insight into the introduction of farming to England, and more.